The Big Picture: Is bigger really better?By Kathy Kincade, EditorWhen shopping for my Christmas tree last month, I encountered an annual dilemma: How big a tree did I want, and how much was I willing to pay for it?Fortunately, my son Tommy was
By Kathy Kincade, Editor
When shopping for my Christmas tree last month, I encountered an annual dilemma: How big a tree did I want, and how much was I willing to pay for it?
Fortunately, my son Tommy was along, and after close evaluation of several yucky trees, he pointed to a 7-foot blue spruce and pronounced it good. I tried not to cringe as I wrote out the $45 check; it was, after all, for a good cause. The small lot was sponsored by the local Boy Scouts.
I have to wonder if purchasing a PACS these days isnt much the same process. Vendors large and small were hawking their wares at the recent RSNA meeting, and after a while it was difficult to tell one system from another. In fact, the market has become so crowded and competitive that customers are increasingly turning to third parties to help them make their buying decisions.
With the industrys ongoing consolidation and growing activity from large information-systems firms, some market watchers believe that there will be less room for the startups and technology innovators that have helped spur this industry to the brink of success.
Not surprisingly, the smaller vendors I talked to at the RSNA meeting take issue with that viewpoint. Most report healthy sales as the technology migrates to the desktop and the market expands into smaller hospitals and clinics. With their nimble organizations and speed in bringing new technology to market, these firms believe they are better positioned than their larger counterparts to meet this growing demand.
Lets hope they are right. Too many choices may be overwhelming, but too few can hinder innovation and success.
© 2000 Miller Freeman, Inc., a United News & Media company.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.